CoverMyMeds is a healthcare technology company that provides an online platform for physicians and pharmacists to obtain quick insurance approvals for new prescriptions. Their technology streamlines the process of submitting prior authorization requests to health insurance plans, enabling faster approvals.
CoverMyMeds' business model involves charging pharmaceutical manufacturers fees for facilitating the prior authorization process, which helps increase sales by expediting approvals. The company was founded in 2008 and was acquired by McKesson Corp., a USD 50 billion healthcare company based in Texas, for USD 1.4 billion in 2017.
As of December 2021, CoverMyMeds generated USD 3.2 billion in revenue and USD 400 million in profits for the nine-month period ending December 2021, making it the most profitable division of McKesson Corp. However, in March 2023, the company announced layoffs of 815 employees and plans to lease out space in its newly-built Franklinton, Ohio headquarters campus to align staffing with customer contracts and manage investments more efficiently, citing the need for "long-term sustainable growth.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.